semaglutide mash GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT FOR SERIOUS LIVER DISEASE Semaglutide, a medication already known for its role in weight management, is now the first GLP-1 therapy approved to treat (Metabolic Dysfunction–Associated GLP-1 therapies: a new frontier

All research referenced in this article was conducted in animal models or in vitro systems

Kansanen et al., 2013)

Circadian rhythm of homocysteine: A study in healthy adults showed that homocysteine levels vary by about 3mol/L over the course of a day

H., & Patchett, A

Importantly, the vast majority of the available PCOS models are generated by exogenous administration of androgens during specific developmental windows, which hampers evaluation of the effects of treatments on endogenous androgen secretion and ovarian function

Key takeaways Bad reactions to semaglutide Costs incurred by patients Supply chain issues Weighing the drawbacks and dangers of semaglutide Sources American Society of Anesthesiologists